Evidence map›Paper›PMID 42261871›Full record

ArticleThe journal of physical chemistry. B2026

The Monomeric Conformational Ensembles of Aβ40 and Aβ42 Encode Their Differential Amyloid Aggregation Propensity.

Irene Cadenelli, Andrea Ciccolo, Andrea Tagliabue, Giulia Rossi, Valeria Conti Nibali, Davide Bochicchio

Abstract read
In one paragraph

Article in The journal of physical chemistry. B, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Irene CadenelliDepartment of Physics, University of Genoa, Genoa 16146, Italy.
Andrea CiccoloDepartment of Mathematical and Computational Sciences, Physical Sciences and Earth Sciences, University of Messina, Messina 98166, Italy.
Andrea TagliabueDepartment of Physics, University of Genoa, Genoa 16146, Italy.ORCID 0000-0001-9520-0627
Giulia RossiDepartment of Physics, University of Genoa, Genoa 16146, Italy.ORCID 0000-0001-6916-2049
Valeria Conti NibaliDepartment of Mathematical and Computational Sciences, Physical Sciences and Earth Sciences, University of Messina, Messina 98166, Italy.
Davide BochicchioDepartment of Physics, University of Genoa, Genoa 16146, Italy.ORCID 0000-0002-3682-9086

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aβ40 and Aβ42 peptides differ by just two C-terminal residues, yet they display strikingly different aggregation and toxicity profiles. Whether this distinction is already encoded at the monomer level is still under debate. Here, we combine extensive all-atom simulations in explicit solvent, well-tempered metadynamics, and a tailored consensus cluster analysis to compare the monomeric ensembles of the two isoforms under identical conditions. Both peptides populate broad, coil-like conformational distributions; however, Aβ42 shows a systematically higher β-structure propensity, especially in the C-terminal region, and samples more extended conformations with higher hydrophobic exposure compared to Aβ40. These results support a mechanistic link between sequence-encoded monomer conformational preferences and the differential amyloidogenicity of the two isoforms, highlighting monomer-level determinants of Aβ42's distinct aggregation behavior.

Indexed as

Amyloid beta-PeptidesPeptide FragmentsAmino Acid SequenceHydrophobic and Hydrophilic InteractionsMolecular Dynamics SimulationProtein AggregatesProtein ConformationProtein Structure, SecondaryAmyloid beta-Peptidesamyloid beta-protein (1-40)amyloid beta-protein (1-42)Peptide FragmentsProtein Aggregates

Identifiers

PMID42261871
PMCPMC13288636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.